Mentat® ameliorates hypoxia-induced attention deficyt hyperactivity disorder like behavior in rats
DOI:
https://doi.org/10.15584/ejcem.2022.3.7Keywords:
ADHD, herbal, Mentat®, neonatal hypoxia, neuroprotectiveAbstract
Introduction and aim. The objective of the study was to evaluate the effect of Mentat® an herbal formulation in experimental models of hypoxia-induced attention deficit hyperactive disorder (ADHD) like behavior in rats.
Material and methods. Mentat® was evaluated at the dose of 100 and 200 mg/kg body weight. per oral., in two experimental models of hypoxia in Wistar rats. In the first model, after parturition, on a postnatal day 2 (PND-2), the pups were subjected to hypoxic exposure for 10 minutes to induce neonatal hypoxia. Pups were weaned from dams on PND-21 and subjected to drug treatments for 10 days. In the second model, phenytoin 150 mg/kg. b.wt. p.o. was administered orally to all pregnant animals throughout gestation to induce intrauterine hypoxia. Pups were subjected to assigned treatments after weaning. Behavioral and biochemical parameters relevant to ADHD were assessed.
Results. In the positive control group, hypoxic exposure resulted in significant changes in cognitive and neurologic skills compared to normal control. Open field test, elevated plus maze test, and Acetylcholine esterase levels showed a significant increase in positive control compared to normal control. In treatment groups, there was a dose-dependent decrease in all the above parameters compared to positive control. Dopamine and Nor-epinephrine levels in brain homogenate were decreased in positive control which subsequently increased with Mentat® treatment.
Conclusion. Mentat® showed a neuroprotective effect in different experimental models of ADHD. It may be recommended for the effective/preventive management of ADHD, especially associated with memory impairment and neurologic conditions.
Downloads
References
van der Kooij MA, Glennon JC. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neurosci Biobehav Rev. 2007;31(4):597-618.
Faraone SV, Banaschewski T, Coghill D, et al. The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789-818.
van Hienen FJ. Organophosphate based pesticides and ADHD 2010. https://studenttheses.uu.nl/. Accessed 21 June 2022.
Rigan S. RANG & DALES Pharmacology 9th edition (TRUE PDF). Elsevier; 2012.
Kim HJ, Joo SH, Choi IH, et al. Effects of Red Ginseng on neonatal hypoxia-induced hyperacitivity phenotype in rats. J. Ginseng Re. 2010;34(1):8-16.
Dogra P, Lata S. ADHD: Pathophysiology, Management, and Assessment Scales. JMSCR. 2018;6:341-347.
Saha A, Bhatia BD, Kulkarni KS. Evaluation of the efficacy of Mentat in children with learning disability: a placebo-controlled double-blind clinical trial. Neurosci Today. 2002;6(3):184-188.
Sharma AK, Agrawal A, Agrawal U, et al. Influence of mentat on memory and mental fatigue in cases of anxiety neurosis and depression. Ind J Cancer & Bio Res. 1990;68(7.58):90-95.
Dave UP, Chauvan V, Dalvi J. Evaluation of br-16 a (mentat) in cognitive and behavioural dysfunction of mentally retarded children—a placebo-controlled study. Ind J Paed. 1993;60(3):423-428.
Dhingra D, Goyal PK. Inhibition of MAO and GABA: probable mechanisms for antidepressant-like activity of Nardostachys jatamansi DC. in mice. Indian J Exp Biol. 2008;46: 212-218.
Pitchaiah G, Viswanatha GL, Srinath R, et al. Anxiolytic and anticonvulsant activity of aqueous extract of stem bark of Erythrina variegata in rodents. Int J Parm Tech Res. 2010;2(1):40-48.
Naewla S, Sirichoat A, Pannangrong W, et al. Hesperidin alleviates methotrexate-induced memory deficits via hippocampal neurogenesis in adult rats. Nutrients. 2019;11(4):936.
National institute of mental health. U.S. https://www.nih.gov/. Accessed: July 21, 2022.
Kulkarni SK, Singh K, Bishnoi M. Comparative behavioral profile of newer antianxiety drugs on different mazes. Indian J Exp Biol. 2008;46: 633-638.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72(1-2):248-254.
Wills E. Mechanisms of lipid peroxide formation in animal tissues. Biochemic J. 1966;99(3):667.
Kharbangar A, Khynriam D, Prasad SB. Effect of cisplatin on mitochondrial protein, glutathione, and succinate dehydrogenase in Dalton lymphoma-bearing mice. Cell Biol Toxicol. 2000;16(6):363-373.
Ellman GL, Courtney KD, Andres Jr V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7(2):88-95.
Mach M, Dubovický M, Navarová J, et al. Experimental modeling of hypoxia in pregnancy and early postnatal life. Interdiscip Toxicol. 2009;2(1):28.
Romm AJ, Romm T. ADHD alternatives: A natural approach to treating Attention-Deficit Hyperactivity Disorder. Storey Publishing; 2000.
Feldman R. Child development, 4th edition. Upper Saddle River, NJ: Pearson Prentice Hall. An overview of child development. Middle Childhood Years and Cognitive Development. MD, Gelfand; 2008.
Allen KE, Allen CG. The Exceptional Child. Albany: Delmar Publishers; 2010.
ADDitude - ADD & ADHD Symptom Tests, Signs, Treatment, Support n.d. https://www.additudemag.com. Accessed: December 21, 2021.
Viswanatha GL, Kumar LM, Rafiq M, et al. LC-MS/MS profiling and neuroprotective effects of Mentat® against transient global ischemia and reperfusion–induced brain injury in rats. Nutrition. 2015;1,31(7-8):1008-1017.
Hillard CJ. Role of cannabinoids and endocannabinoids in cerebral ischemia. Curr Pharm Des. 2008;14(23):2347-2361.
Himalaya Mentat Tablets - Enhances Memory – Himalaya Wellness (India) n.d. https://himalayawellness.in/products/mentat. Accessed: December 21, 2021.
Scheuer C, Boot E, Carse N, et al. Disentangling inclusion in physical education lessons: Developing a resource toolkit for teachers. In: Physical Education and Sport for Children and Youth With Special Needs Researches–Best Practices–Situation. Slovakia; Slovak Scientific Society for Physical Education and Sport and FIEP: 2021; 343-354.
Miguel PM, Schuch CP, Rojas JJ, et al. Neonatal hypoxia-ischemia induces attention-deficit hyperactivity disorder-like behavior in rats. Behav Neurosci. 2015;129(3):309.
Prince J. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update. J Clin Psychopharmacol. 2008;28(3):39-45.
Katz M, Adar Levine A, Kol-Degani H, et al. A compound herbal preparation (CHP) in the treatment of children with ADHD: a randomized controlled trial. J Atten Disord. 2010;14(3):281-291.
Zahiruddin S, Basist P, Parveen A, et al. Ashwagandha in brain disorders: A review of recent developments. J Ethnopharmacol. 2020;257:112876.
Negi J. The ayurvedic pharmacopoeia of india the ayurvedic pharmacopoeia of India. Part - II. Government of India Ministry of Health and Family welfare department of Ayush. http://www.ayurveda.hu/. Accessed: July 21, 2022.
Suhani S, Soubhik K. Effects and safety profile of commonly used herbal anti-diabetic preparations. GSC biol pharm sci.2018;4(2).66-79.
Sethiya NK, Nahata A, Mishra SH, et al. An update on Shankhpushpi, a cognition-boosting Ayurvedic medicine. Chin J Integr Med. 2009;7(11):1001-1022.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
